Your browser doesn't support javascript.
loading
Immune checkpoint inhibitor-associated hemophagocytic lymphohistiocytosis in a patient with chronic lymphocytic leukemia.
Ali, Syed B; Kuss, Bryone; Karapetis, Chris; Hughes, Tiffany; Smith, Anthony.
Afiliación
  • Ali SB; Department of Clinical Immunology & Allergy, Flinders Medical Centre, Bedford Park, Australia.
  • Kuss B; School of Medicine & Public Health, Flinders University, Bedford Park, 5042, Australia.
  • Karapetis C; Department of Haematology, Flinders Medical Centre, Bedford Park, 5042, Australia.
  • Hughes T; Department of Oncology, Flinders Medical Centre, Bedford Park, 5042, Australia.
  • Smith A; Department of Clinical Immunology & Allergy, Flinders Medical Centre, Bedford Park, Australia.
Immunotherapy ; 15(18): 1531-1537, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37933523
A 55-year-old man had skin cancer and treatment was started. He also had a blood cancer around the same time that was not causing any problems. The skin cancer treatment started to cause problems many weeks later. His immune system started to react and become more active and so his liver started to suffer. The treatment for his skin cancer was stopped and steroids were started, which eventually improved his condition. These treatments for skin cancer can activate the immune system, but to this extent is not very common. It is important to know that it is possible and needs to be actioned early.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombocitopenia / Leucemia Linfocítica Crónica de Células B / Linfohistiocitosis Hemofagocítica Límite: Humans / Male / Middle aged Idioma: En Revista: Immunotherapy Asunto de la revista: ALERGIA E IMUNOLOGIA / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombocitopenia / Leucemia Linfocítica Crónica de Células B / Linfohistiocitosis Hemofagocítica Límite: Humans / Male / Middle aged Idioma: En Revista: Immunotherapy Asunto de la revista: ALERGIA E IMUNOLOGIA / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido